AGP Executive Report
Last update: 5 hours agoVaccine Manufacturing: Zambia has broken ground on the $24.1 million first phase of the ZAMVAX plant in Lusaka, designed to fill and finish up to 20 million cholera vaccine doses a year. The joint venture with China’s Jijia Medical Technology aims to reduce reliance on imports. Nuclear Energy: An IAEA review says Zambia is building the institutions and infrastructure needed to assess nuclear power, while identifying more work required before a decision. Advanced Healthcare: UTH has activated Zambia’s first cochlear implant, beginning rehabilitation for a 20-year-old patient and marking progress in local specialist care. Digital Health: Zambia has deployed 751 Starlink kits to health facilities with UNDP support, while CIDRZ and the Ministry of Health are using digital monitoring to track the rollout of new HIV-prevention options, including Lenacapavir.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.